|
|
|
| Clinical effect of Tongqiao Biyan Tablets combined with Pidotimod in treatment of allergic rhinitis in children |
| WANG Qing ZHAO Jian-bo |
| Department of Pediatrics,the Second People′s Hospital of Yichun City,Jiangxi Province,Yichun 336000,China |
|
|
|
|
Abstract Objective To explore the clinical effect of Tongqiao Biyan Tablets combined with Pidotimod Oral Liquid in the treatment of allergic rhinitis in children.Methods A total of 84 children with allergic rhinitis admitted in the Second People′s Hospital of Yichun City from January 2020 to September 2020 were selected as the research subjects,and they were divided into the control group(42 cases)and the study group(42 cases)by random number table method.The control group was treated with Pidotimod Oral Liquid,and the study group was treated with Tongqiao Biyan Tablets combined with Pidotimod Oral Liquid.The clinical effect,levels of inflammatory cytokine,clinical symptom scores and adverse reactions were compared between the two groups.Results The total effective rate in the study group was 92.86%,which was higher than that in the control group(76.19%),and the difference was statistically significant(P＜0.05).Before treatment,there were no significant differences in the levels of interleukin-5(IL-5)and tumor necrosis factor-α(TNF-α)between the two groups(P＞0.05).After treatment,the levels of IL-5 and TNF-α in the study group were(10.21±0.87)pg/ml and(26.29±3.67)mg/ml,respectively,which were lower than those in the control group of(12.36±1.26)pg/ml and(36.51±4.64)mg/ml,with statistical significances(P＜0.05).Before treatment,there were no significant differences in sneeze frequency score,nasal overflow score,nasal obstruction score and the total score between the two groups(P＞0.05).After treatment,the sneeze frequency score,nasal overflow score,nasal congestion score and total score of the study group were(0.92±0.08),(1.12±0.11),(1.04±0.13),(3.08±0.32)points,respectively,which were lower than those in the control group of(1.36±0.18),(1.64±0.21),(1.67±0.24)and(4.67±0.63)points,with statistical significances(P＜0.05).There was no significant difference in the total incidence of adverse reactions between the two groups(P＞0.05).Conclusion Tongqiao Biyan Tablets combined with Pidotimod Oral Liquid can effectively relieve the clinical symptoms of allergic rhinitis in children,reduce the level of inflammatory cytokin,and has obvious effect and high application value.
|
|
|
|
|
|
| [1] |
谢成彬，唐凤翔，廖兵.富马酸卢帕他定治疗过敏性鼻炎的临床疗效观察[J].重庆医学，2018，47（23）：3064-3067.
|
| [2] |
孙雪梅，周高俊.氯雷他定联合糠酸莫米松鼻喷雾剂治疗儿童变应性鼻炎的疗效分析[J].北京医学，2017，39（7）：711，714.
|
| [3] |
喻望博，李蕊，李婉，等.鼻渊通窍颗粒联合匹多莫德治疗儿童过敏性鼻炎的临床研究[J].西部医学，2019，31（3）：412-415，421.
|
| [4] |
朱潇月.通窍鼻炎片联合克拉霉素治疗慢性鼻窦炎的临床研究[J].现代药物与临床，2019，34（12）：3612-3615.
|
| [5] |
宋伟琪，安玉峰，张亚波，等.丙酸氟替卡松鼻喷雾剂同通窍鼻炎胶囊治疗变应性鼻炎疗效观察[J].中国药物与临床，2020，20（19）：3184-3186.
|
| [6] |
中华耳鼻咽喉头颈外科杂志编辑委员会鼻科组，中华医学会耳鼻咽喉头颈外科学分会鼻科学组、小儿学组，中华儿科杂志编辑委员会.儿童变应性鼻炎诊断和治疗指南（2010年，重庆）[J].中华耳鼻咽喉头颈外科杂志，2011，46（1）：7-8.
|
| [7] |
江华，赵娟，张秋，等.苍耳子鼻炎滴丸联合孟鲁司特治疗儿童变应性鼻炎疗效研究[J].陕西中医，2018，39（7）：37-39.
|
| [8] |
陈竹.丙酸氟替卡松鼻喷雾剂治疗儿童过敏性鼻炎疗效及对患儿免疫功能的影响[J].中国妇幼保健，2018，33（12）：2744-2746.
|
| [9] |
樊晋萍，单宝英，倪新强，等.鼻渊通窍颗粒联合匹多莫德治疗儿童过敏性鼻炎的临床研究[J].现代药物与临床，2017，32（8）：1486-1490.
|
| [10] |
崔怀亮，可秋萍，娄莹，等.玉屏风颗粒联合匹多莫德对变应性鼻炎合并支气管哮喘的临床疗效探究[J].中华中医药学刊，2019，37（8）：2039-2041.
|
| [11] |
颜国.匹多莫德分散片联合玉屏风颗粒对小儿反复呼吸道感染的疗效及机制研究[J].中国药物与临床，2019，19（24）：4319-4321.
|
| [12] |
王艳.通窍鼻炎颗粒联合西替利嗪滴剂治疗儿童过敏性鼻炎的疗效分析[J].儿科药学杂志，2017，23（3）：30-32.
|
| [13] |
杨娜，柳荫，成晨.通窍鼻炎颗粒对变应性鼻炎患儿的临床疗效研究[J].世界临床药物，2019，40（12）：862-866.
|
| [14] |
林琛，竺维娜，汪际云.通窍鼻炎颗粒联合激素喷剂对过敏性鼻炎患者血清炎症因子和鼻腔生理功能的影响[J].中华中医药学刊，2018，36（4）：959-962.
|
| [15] |
吴方星，熊高云，戈言平，等.通窍鼻炎颗粒对变应性鼻炎患者炎性因子免疫球蛋白及嗜酸性粒细胞水平的影响[J].中国药物与临床，2019，19（3）：358-360.
|
|
|
|
